About Apexigen, Inc.
Apexigen, Inc. is an emerging biopharmaceutical company focused on the development of best-in-class antibody therapeutics for the treatment of cancer and other serious diseases. Apexigen has a robust antibody platform technology and a pipeline of seven humanized antibody product candidates. Apexigen's proprietary antibody technologies produce a broad diversity of antibodies with high specificity and high affinity against unique epitopes. It can successfully generate antibodies against challenging antigens where competing technologies fail. This technology allows Apexigen to identify antibodies with unique functional characteristics for optimal therapeutic benefit.
Developing its product pipeline through collaborations is an important aspect of Apexigen's business model. Several antibodies derived from its technology have been licensed to companies in China who are developing them for commercialization there. In addition, Apexigen has also licensed the use of its antibody technologies to multinational companies for use in the development of therapeutics worldwide. Additional information is available at www.apexigen.com.
About Gansu Duyiwei Biological Pharmaceutical Co., Ltd.
Gansu Duyiwei Biological Pharmaceutical Co., Ltd. is located in Kang County, Longnan city , Gansu Province. As the first pharmaceutical company listed on Shenzhen Stock Exchange in Gansu Province, the company has developed very fast in recent years.
As an important Chinese patent medicine and crude drug company
|SOURCE Apexigen, Inc.|
Copyright©2010 PR Newswire.
All rights reserved